Değer202020212022202320242025TTMSatış/genel/idari giderler735.27 M796.39 M850.75 M901.89 M1.03 B1.05 B1.09 BAraştırma ve geliştirme141.25 M161.01 M254.82 M190.95 M219.79 M251.21 M257.93 MFaaliyet karı694.52 M932.03 M898.76 M1.1 B1.13 B1.36 B1.41 BFaaliyet Dışı Gelir, Toplam600 K-2.1 M-3.4 M-1.1 M-4.5 M-4.2 M—Faiz gideri (aktifleştirilmiş faizler düşüldükten sonra)33.13 M29.81 M39.86 M41.58 M31.2 M38.85 M38.93 MFaaliyet Dışı Gelir (Faiz Giderleri Hariç)-32.52 M-31.91 M-43.26 M-42.68 M-35.7 M-43.05 M—Olağandışı gelirler/giderler———————Vergi öncesi kar661.99 M902.65 M859.97 M1.06 B1.11 B1.32 B1.37 BKazançlardaki özsermayeler———————Vergiler79.85 M157.81 M180.88 M216.13 M221.96 M264.73 M274.31 MKontrol gücü olmayan/azınlık payı355 K-1 00000———Vergi sonrası diğer gelirler/giderler———————Durdurulan faaliyetler öncesi net kar581.78 M744.85 M679.09 M845.04 M887.87 M1.06 B1.1 BDurdurulan faaliyetler———————Net kar581.78 M744.85 M679.09 M845.04 M887.87 M1.06 B1.1 BSeyreltme ayarlaması———————İmtiyazlı temettüler———————Adi hisse senedi sahiplerine düşen seyreltilmiş net kar581.78 M744.85 M679.09 M845.04 M887.87 M1.06 B1.1 BTemel hisse başına kazanç (Temel EPS)6.828.748.1210.1710.7713.1713.69Seyreltilmiş hisse başına kazanç (Seyreltilmiş EPS)6.718.68.0310.0610.6713.0813.59Dolaşımdaki ortalama adi hisse senedi sayısı85.34 M85.2 M83.62 M83.07 M82.47 M80.43 M—Dolaşımdaki seyreltilmiş hisse senedi sayısı86.72 M86.57 M84.6 M83.98 M83.25 M81.03 M—FAVÖK687.18 M1.57 B1.67 B1.84 B1.24 B1.49 B1.54 BFVÖK591.18 M1.47 B1.55 B1.73 B1.11 B1.34 B1.39 BGelir maliyeti1.14 B1.33 B1.36 B1.47 B1.53 B1.65 B1.7 BSatılan malların diğer maliyeti———————Amortisman ve itfa (nakit akışı)96 M104.6 M111.9 M114.91 M129.94 M145.18 M148.8 M
IDEXX Laboratories, Inc. - Common Stock
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.